| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703107 | Null | 0.0375780807984392 | 0.117302 |
| NSC 704565 | Null | 0.0375780807984392 | 0.36812909 |
| NSC 276371 | 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- | 0.0430505868034758 | 0.11778781 |
| NSC 622124 | Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) | 0.0430505868034758 | 0.22120845 |
| NSC 681643 | Camptothecin Derivative | 0.0430505868034758 | 0.11276918 |
| NSC 681646 | Camptothecin Derivative | 0.0430505868034758 | 0.143054 |
| NSC 710549 | Null | 0.0430505868034761 | 0.52150277 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0430505868034761 | 0.46541347 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0430505868034761 | 0.266731 |
| NSC 732178 | Null | 0.0430505868034761 | 0.019232521 |